170 related articles for article (PubMed ID: 22132593)
1. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic.
Dunican E; Uzbeck M; Clince J; Toner S; Royston D; Logan MP; Breathnach O; Young V; Linnane SI; Morgan RK
Ir Med J; 2011 Oct; 104(9):265-8. PubMed ID: 22132593
[TBL] [Abstract][Full Text] [Related]
2. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
3. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer patients with previous or simultaneous the upper aerodigestive cancers.
Kagohashi K; Satoh H; Kurishima K; Ishikawa H; Ohtsuka M; Sekizawa K
Tuberk Toraks; 2009; 57(2):192-7. PubMed ID: 19714511
[TBL] [Abstract][Full Text] [Related]
5. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
Stevens W; Stevens G; Kolbe J; Cox B
Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
7. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
8. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
10. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.
Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM
Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281
[TBL] [Abstract][Full Text] [Related]
12. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
[TBL] [Abstract][Full Text] [Related]
14. [In which stage we diagnose and how we treat lung cancer?].
Oztuna F; Ozlü T; Bülbül Y
Tuberk Toraks; 2003; 51(2):152-6. PubMed ID: 15143421
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
Dillman RO; Seagren SL; Propert KJ; Guerra J; Eaton WL; Perry MC; Carey RW; Frei EF; Green MR
N Engl J Med; 1990 Oct; 323(14):940-5. PubMed ID: 2169587
[TBL] [Abstract][Full Text] [Related]
16. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):538-46. PubMed ID: 21684554
[TBL] [Abstract][Full Text] [Related]
17. Bibliography. Current world literature. Lung and mediastinum.
Curr Opin Oncol; 2004 Mar; 16(2):184-97. PubMed ID: 15083801
[No Abstract] [Full Text] [Related]
18. Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer.
Kyasa MJ; Jazieh AR
South Med J; 2002 Oct; 95(10):1149-52. PubMed ID: 12425499
[TBL] [Abstract][Full Text] [Related]
19. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
20. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
